Gastric cancer pathology and underlying molecular mechanisms.
about
Molecular alterations in gastric cancer with special reference to the early-onset subtypeGenomic and epigenomic heterogeneity in molecular subtypes of gastric cancerMolecular Dimensions of Gastric Cancer: Translational and Clinical PerspectivesSystemic treatment of gastric and esophageal adenocarcinoma in elderly patientslet-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort studyFilamin C, a dysregulated protein in cancer revealed by label-free quantitative proteomic analyses of human gastric cancer cellsClinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancerAblation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism.Recent advances and future trends in the targeted therapy of metastatic gastric cancer.The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer.Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.A global burden of gastric cancer: the major impact of China.Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.The course of gastric cancer following surgery is associated with genetic variations of the interleukin-1 receptor antagonist and interleukin-1β.Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy.Telomere length is correlated with mitochondrial DNA copy number in intestinal, but not diffuse, gastric cancer.RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expressionC-C motif chemokine receptors in gastric cancer.The intricate interplay between MSI and polymorphisms of DNA repair enzymes in gastric cancer H.pylori associated.[Spindle-cell osteosclerotic bone lesion with MDM2 amplification].Genetics of gastric cancer.A proteomic landscape of diffuse-type gastric cancer.Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients.Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy.Characteristics and predictors of gastric cancer after Helicobacter pylori eradication.Downregulation of peroxiredoxin II suppresses the proliferation and metastasis of gastric cancer cellsGankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 ActivationMetabolomic alterations and chromosomal instability status in gastric cancer
P2860
Q26764919-410079EE-DD11-4D0F-A78A-B887EEFF1C52Q26774509-206BEBE1-37A5-4CAF-80A2-C487763D36C0Q26779725-74EE4E90-CC12-48C6-81DE-55BD29194A4AQ28088453-5935D12B-60A8-4717-B370-9EB062291D4EQ34333720-7BF65FD4-7041-498C-8408-515B6B6661D0Q35135769-33F8BD0F-2256-4E2F-B5A8-5AF1D922337DQ35176043-6D146E77-B1E0-43D2-A9EE-4E1ACF188192Q36536744-9FD31512-25F8-4841-9BB0-BB5B0B9031FAQ37216983-A73CFF1A-A241-4E4A-9827-090A0BFF8D07Q37636765-38FEDCCC-E9A1-49CD-BFBB-78DC8FEFF4A1Q38199128-542E528C-2A46-41D0-95CD-2F71F9F44B63Q38297145-7344C4AE-5AEF-4891-A70D-403E8A4E6FC8Q38651789-645D70F7-A61C-497B-BD20-2C90B73D8C1AQ38738402-6C303746-60DF-4916-96D5-75CA7FC6062DQ38843125-92BB282C-8C27-4247-AA09-CB6441536DE6Q38971368-2FBDAEEA-AD1B-4C61-9218-66BA0B15C795Q39247168-0899BED8-1A70-4D44-BD93-BDB770C1BFEAQ39838743-505456B0-5C04-4F67-A952-42E4E9F8AD0CQ40979369-F807B3B2-10E5-41E1-924C-A1102E76FDCAQ41412828-E8D86747-D033-4B65-85CB-9C8DEF1F1E5FQ47163024-AD0EA2EA-E9FF-4472-AF5B-2281F0D64267Q47960421-35C67A9F-D693-4DC4-8701-74F1E6FD383AQ50055509-F4AE505F-0CFD-48B6-8BC2-8D259DF750DAQ51219045-9A48F8FD-FE1C-4577-A85A-C3BA6DEE76F5Q52727768-D7861587-CAA8-46C7-A0DC-B2C331BCAACBQ52907390-A9EE40E4-B761-4680-BD73-FD27C9DD2787Q53225944-D996CFC4-117E-46B8-B165-431ECE3843F9Q55283837-91A284EE-2D58-46C0-8ABF-69D99E5E4EF3Q57922517-457A3B76-BA7F-4E5B-B9E4-22DF8222BBE8Q58699271-CEF5A0A4-4AAD-4D4A-9F99-126887052B23Q58760413-461A7DDF-A69D-43CE-B11A-57442E8F0754
P2860
Gastric cancer pathology and underlying molecular mechanisms.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gastric cancer pathology and underlying molecular mechanisms.
@en
Gastric cancer pathology and underlying molecular mechanisms.
@en-gb
type
label
Gastric cancer pathology and underlying molecular mechanisms.
@en
Gastric cancer pathology and underlying molecular mechanisms.
@en-gb
prefLabel
Gastric cancer pathology and underlying molecular mechanisms.
@en
Gastric cancer pathology and underlying molecular mechanisms.
@en-gb
P356
P1433
P1476
Gastric cancer pathology and underlying molecular mechanisms.
@en
P2093
Patrick Tan
P304
P356
10.1159/000350876
P577
2013-07-18T00:00:00Z